Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.9 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |